Optimized Bexarotene Aerosol Formulation Inhibits Major Subtypes of Lung Cancer in Mice-Reference-Cited by-同舟云学术

Optimized Bexarotene Aerosol Formulation Inhibits Major Subtypes of Lung Cancer in Mice

Published:2019-03-15 Issue:4 Volume:19 Page:2231-2242
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Zhang Qi,Lee Sang Beom,Chen Xu,Stevenson Morgan E¹,Pan Jing,Xiong Donghai,Zhou Yu,Miller Mark Steven²,Lubet Ronald A²,Wang Yian,Mirza Shama P.³,You Ming^ORCID

Affiliation:

1. Department of Psychology, University of Wisconsin, Milwaukee, Wisconsin 53211, United States

2. Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland 20850, United States

3. Department of Chemistry and Biochemistry, University of Wisconsin, Milwaukee, Wisconsin 53211, United States

Funder

National Institutes of Health

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.8b04309

Reference43 articles.

1. Lung Cancer

2. Small cell lung cancer: new clinical recommendations and current status of biomarker assessment

3. Mouse Models Incorporating Alterations In The Major Tumor Suppressor Genes P53 And P16: Their Use In Screening For Potential Carcinogens, Developing Further Relevant Mouse Models, And Screening For Potential Chemopreventive And Chemotherapetutic Agents

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting SEZ6L2 in Colon Cancer: Efficacy of Bexarotene and Implications for Survival;Journal of Gastrointestinal Cancer;2024-07-02

2. Targeting SEZ6L2 in Colon Cancer: Efficacy of Bexarotene and Implications for Survival;2024-06-19

3. Cancer chemoprevention with PV-1, a novel Prunella vulgaris-containing herbal mixture that remodels the tumor immune microenvironment in mice;Frontiers in Immunology;2023-11-24

4. Development and Challenges of Synthetic Retinoid Formulations in Cancer;Current Drug Delivery;2023-11

5. PRIMARY PREVENTION AND INTERCEPTION STUDIES IN RAS-MUTATED TUMOR MODELS EMPLOYING SMALL MOLECULES OR VACCINES;Cancer Prevention Research;2023-07-19